Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.920
+0.010 (0.52%)
Feb 5, 2026, 4:10 PM AEST
Imricor Medical Systems Market Cap
Imricor Medical Systems has a market cap or net worth of 616.22 million as of February 5, 2026. Its market cap has increased by 64.09% in one year.
Market Cap
616.22M
Enterprise Value
577.27M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.92
Market Cap Chart
Since August 30, 2019, Imricor Medical Systems's market cap has increased from 87.01M to 616.22M, an increase of 608.21%. That is a compound annual growth rate of 35.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 613.01M | 24.84% |
| Dec 31, 2025 | 491.05M | 33.64% |
| Dec 31, 2024 | 367.44M | 281.62% |
| Dec 29, 2023 | 96.28M | 74.29% |
| Dec 30, 2022 | 55.24M | -61.62% |
| Dec 31, 2021 | 143.95M | -49.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.11B |
| Anteris Technologies Global | 837.17M |
| PolyNovo | 683.93M |
| Aroa Biosurgery | 239.80M |
| Lumos Diagnostics Holdings | 213.96M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 141.99M |
| Cleo Diagnostics | 91.70M |